Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy.
Agnes BassevilleChiara CordierFadoua Ben AzzouzWilfried GouraudHamza LaslaFabien PanloupMario CamponePascal JézéquelPublished in: Cancer research communications (2022)
The development of personalized and precision medicine is the future of cancer therapy. With only two gene expression signatures approved by FDA for breast cancer, we are in need of new ones that can reliably stratify patients for optimal treatment. This study provides two hormonotherapy-predictive and prognostic signatures that are related to nervous system in TME. It highlights tumor neuronal components as potential new targets for breast cancer therapy.